Menu
Recruiting NCT07003308

Anterior Versus Posterior White Line Advancement Technique in the Correction of Aponeurotic Ptosis

No phase Interventional Ptosis, Eyelid

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Anterior White Line Advancement Surgery, Posterior White Line Advancement Surgery.
Who it may be relevant to
Registry conditions: Ptosis, Eyelid. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Spain
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Comparative Study of the Efficacy of Anterior Versus Posterior White Line Advancement Technique in the Correction of Primary Aponeurotic Ptosis

Overview

The goal of this clinical trial is to compare the efficacy of two surgical techniques-anterior and posterior white line advancement-for the correction of primary aponeurotic ptosis in adult patients. The main questions it aims to answer are: Does the anterior approach lead to a greater improvement in Marginal Reflex Distance 1 (MRD1) at 6 months compared to the posterior approach? Are there differences in eyelid symmetry, contour, visual function, and patient satisfaction between the two techniques? Researchers will compare the anterior approach group to the posterior approach group to see if one offers better functional and aesthetic outcomes, fewer complications, or higher patient satisfaction. Participants will: Be randomly assigned to receive either anterior or posterior white line advancement surgery. Undergo preoperative and postoperative evaluations at 7 days, 2 months, and 6 months, including: Measurements of eyelid position (MRD1), contour, and symmetry Vision and tear film tests (e.g., refraction, TBUT, Schirmer's test) Surveys on dry eye symptoms (OSDI), scar quality (POSAS 2.0), satisfaction, and psychosocial function Monitoring of surgical time and complications

Detailed description

This is a prospective, randomized, controlled clinical trial designed to compare the efficacy, functional outcomes, aesthetic results, and patient-reported satisfaction associated with two surgical techniques for correcting primary aponeurotic ptosis: anterior white line advancement and posterior white line advancement.

Participants will be randomized 1:1 into two parallel groups. In the anterior approach, access to the levator aponeurosis is achieved via a skin crease incision, and advancement is performed using sutures placed on the white line to reattach it to the anterior surface of the tarsus. In the posterior approach, access is gained through a conjunctival incision above the superior tarsal border, followed by dissection to expose the white line and suture advancement to the anterior tarsus, without a skin incision.

Functional eyelid position will be assessed through MRD1 measurements, symmetry evaluation, and contour analysis. Contour will be quantified objectively using ImageJ software with Bézier curve fitting, and subjectively through independent masked evaluations based on pre-defined criteria.

Patient-reported outcomes will be assessed using the validated FACE-Q Aesthetics questionnaire, including scales for appearance satisfaction, psychosocial function, early recovery, and satisfaction with the surgical outcome and decision. Tear film stability and ocular surface parameters will be assessed using TBUT, Schirmer test (without anesthesia), and the Ocular Surface Disease Index (OSDI).

Standardized digital photographs will be taken at each follow-up visit to ensure consistent evaluation of eyelid contour and aesthetic results. All images and clinical data will be securely stored with restricted access for authorized investigators only.

Follow-up visits are scheduled for Day 7, Month 2, and Month 6 postoperatively. No masking will be applied due to the nature of the surgical techniques; however, outcome assessors for eyelid contour and patient-reported measures will remain blinded to group assignment.

This study aims to generate high-quality comparative data to guide clinical decision-making in the surgical management of aponeurotic ptosis, with an emphasis on both anatomical and patient-centered outcomes.

Interventions

  • Procedure Anterior White Line Advancement Surgery
    This technique involves a skin incision at the eyelid crease, dissection through the orbicularis muscle to expose the tarsus, and proximal dissection in the pre-Müller-conjunctival plane to visualize the white line. A double-armed 5-0 absorbable suture is used to advance the white line to the anterior tarsal surface. Eyelid height and contour are assessed before final fixation. Skin closure is completed with a non-absorbable suture.
  • Procedure Posterior White Line Advancement Surgery
    This conjunctival technique uses a traction suture and eyelid eversion to access the posterior surface of the eyelid. A conjunctival incision is made above the superior tarsal border, followed by dissection to expose the white line. A double-armed 5-0 absorbable suture is passed through the anterior tarsus and the white line, and tied after confirming adequate eyelid position. The conjunctiva is not sutured.

Primary outcome measures

  • Change in Marginal Reflex Distance 1 (MRD1) at 6 Months [Time frame: Baseline (Day 0) and Month 6 (±2 weeks) after surgery]
Secondary outcome measures (12)
  • Change in MRD1 at 2 Months [Time frame: Baseline (Day 0) and Month 2 (±1 week) after surgery]
  • Postoperative Interpalpebral Symmetry at 2 and 6 Months [Time frame: Month 2 (±1 week) and Month 6 (±2 weeks) after surgery]
  • Eyelid Contour Evaluation at 2 and 6 Months [Time frame: Month 2 (±1 week) and Month 6 (±2 weeks) after surgery]
  • Change in Refractive Error at 2 and 6 Months [Time frame: Baseline (Day 0), Month 2 (±1 week), and Month 6 (±2 weeks) after surgery]
  • Change in Corneal Topographic Parameters at 2 and 6 Months [Time frame: Baseline (Day 0), Month 2 (±1 week), and Month 6 (±2 weeks) after surgery]
  • Change in Tear Break-Up Time (TBUT) at 2 and 6 Months [Time frame: Baseline (Day 0), Month 2 (±1 week), and Month 6 (±2 weeks) after surgery]
  • Change in Schirmer Test (without anesthesia) at 2 and 6 Months [Time frame: Baseline (Day 0), Month 2 (±1 week), and Month 6 (±2 weeks) after surgery]
  • Change in Ocular Surface Disease Index (OSDI) Scores at 7 Days, 2 and 6 Months [Time frame: Baseline (Day 0), Day 7 (±1 day), Month 2 (±1 week), and Month 6 (±2 weeks) after surgery]
  • Change in Aesthetic Satisfaction Scores at 2 Months [Time frame: Baseline (Day 0) and Month 2 (±1 week) after surgery]
  • Change in Psychosocial Function Scores at 2 Months [Time frame: Baseline (Day 0) and Month 2 (±1 week) after surgery]
  • Assessment of Early Symptom Recovery at 7 Days [Time frame: Day 7 (±1 day) after surgery]
  • Satisfaction with Surgical Outcome and Decision at 2 Months [Time frame: Month 2 (±1 week) after surgery]

Eligibility criteria

Inclusion criteria

  • Age over 18 years.
  • Diagnosis of primary aponeurotic upper eyelid ptosis.
  • Levator muscle function of 12 mm or greater.
  • Provision of written informed consent after receiving adequate information about the study.

Exclusion criteria

  • Diagnosis of non-aponeurotic eyelid ptosis.
  • Poor levator muscle function.
  • History of recurrent eyelid ptosis or previous eyelid ptosis surgery.
  • Medical or surgical history that, in the investigator's judgment, may interfere with participation.
  • Individuals with childbearing potential who are not using highly effective contraception methods.
  • Refusal to participate in the study or to sign the informed consent form.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Treatment

Study locations

Spain · 1 center
  • Rey Juan Carlos Hospital — Móstoles

Publications

  • Shen Y, Yu W, Ding F, Lu L, Liu F, Sun D, Luo X, Jin R, Yang J. Aesthetic Correction of Mild-to-Moderate Blepharoptosis Among Asians: The Bridge Technique. Ophthalmol Ther. 2022 Feb;11(1):151-160. doi: 10.1007/s40123-021-00417-3. Epub 2021 Nov 6. PMID 34741757
  • Ozturk Karabulut G, Fazil K. Corneal Topographical Changes After Muller's Muscle-conjunctival Resection Surgery. Ophthalmic Plast Reconstr Surg. 2019 Mar/Apr;35(2):177-181. doi: 10.1097/IOP.0000000000001203. PMID 30130332
  • Inal Ozen M, Demirok G, Yalniz Akkaya Z, Akbas Kocaoglu F, Katircioglu Y, Celik T, Ornek F, Acar DD. Effect of upper eyelid blepharoplasty surgery on cornea biomechanics and ocular surface. Int Ophthalmol. 2024 Sep 22;44(1):386. doi: 10.1007/s10792-024-03313-4. PMID 39306627
  • Aksu Ceylan N, Yeniad B. Effects of Upper Eyelid Surgery on the Ocular Surface and Corneal Topography. Turk J Ophthalmol. 2022 Feb 23;52(1):50-56. doi: 10.4274/tjo.galenos.2021.63255. PMID 35196840
  • Bilici S, Harbigil-Sever T, Ugurbas SH. Digital analysis of unilateral ptosis repair: external levator advancement vs. Muller's muscle conjunctival resection. Arq Bras Oftalmol. 2024 Mar 22;87(3):e20230028. doi: 10.5935/0004-2749.2023-0028. eCollection 2024. PMID 38537045
  • Schulz CB, Nicholson R, Penwarden A, Parkin B. Anterior approach white line advancement: technique and long-term outcomes in the correction of blepharoptosis. Eye (Lond). 2017 Dec;31(12):1716-1723. doi: 10.1038/eye.2017.138. Epub 2017 Aug 11. PMID 28799556
  • Patel V, Salam A, Malhotra R. Posterior approach white line advancement ptosis repair: the evolving posterior approach to ptosis surgery. Br J Ophthalmol. 2010 Nov;94(11):1513-8. doi: 10.1136/bjo.2009.172353. Epub 2010 Sep 10. PMID 20833687
  • Sagili S. Anterior Approach White-Line Advancement: A Hybrid Technique for Ptosis Correction. Ophthalmic Plast Reconstr Surg. 2015 Nov-Dec;31(6):478-81. doi: 10.1097/IOP.0000000000000543. PMID 26325380

Identifiers

NCT: NCT07003308 · EC054-25_HRJC

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗